RxSight (RXST) Revenue & Revenue Breakdown
RxSight Revenue Highlights
Latest Revenue (Y)
$89.08M
Latest Revenue (Q)
$45.52M
Main Segment (Y)
L D D
Main Geography (Y)
L D D
RxSight Revenue by Period
RxSight Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $89.08M | 81.77% |
2022-12-31 | $49.01M | 116.90% |
2021-12-31 | $22.59M | 53.92% |
2020-12-31 | $14.68M | 554.98% |
2019-12-31 | $2.24M | - |
RxSight Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $45.52M | 54.26% |
2024-03-31 | $29.51M | 3.26% |
2023-12-31 | $28.58M | -6.81% |
2023-09-30 | $30.67M | 47.37% |
2023-06-30 | $20.81M | 18.99% |
2023-03-31 | $17.49M | 8.71% |
2022-12-31 | $16.09M | 27.53% |
2022-09-30 | $12.62M | 11.05% |
2022-06-30 | $11.36M | 27.04% |
2022-03-31 | $8.94M | 6.11% |
2021-12-31 | $8.43M | 45.64% |
2021-09-30 | $5.79M | 18.15% |
2021-06-30 | $4.90M | 40.56% |
2021-03-31 | $3.48M | -29.10% |
2020-12-31 | $4.91M | 17.84% |
2020-09-30 | $4.17M | 54.10% |
2020-06-30 | $2.71M | -6.30% |
2020-03-31 | $2.89M | - |
RxSight Revenue Breakdown
RxSight Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 |
---|---|
Service Warranty Service Contracts And Accessories | $656.00K |
L A L | $8.16M |
L D D | $13.77M |
Quarterly Revenue by Product
Product/Service | Jun 24 | Mar 24 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
---|---|---|---|---|---|---|---|---|---|---|
L D D | $10.19M | $8.71M | $7.72M | $6.47M | $5.69M | $5.68M | $4.57M | $5.31M | $3.66M | $2.96M |
Service Warranty Service Contracts And Accessories | $870.00K | $882.00K | $679.00K | $619.00K | $401.00K | $328.00K | $268.00K | $216.00K | $181.00K | $140.00K |
RxLAL | - | - | - | - | - | - | $4.11M | $1.94M | - | - |
L A L | - | - | - | - | - | - | - | - | - | $1.79M |
RxSight Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 |
---|---|
L D D | $13.77M |
Service Warranty Service Contracts And Accessories | $656.00K |
L A L | $8.16M |
RxSight Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
VREX | Varex Imaging | $893.40M | $209.10M |
FNA | Paragon 28 | $216.39M | $61.02M |
AXGN | AxoGen | $159.01M | $47.91M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SIBN | SI-BONE | $138.89M | $39.97M |
RXST | RxSight | $89.08M | $45.52M |
SGHT | Sight Sciences | $81.06M | $21.37M |
LUNG | Pulmonx | $68.67M | $20.78M |
VAPO | Vapotherm | $68.67M | $16.88M |
IRMD | IRadimed | $65.56M | $17.93M |
NPCE | NeuroPace | $65.42M | $18.12M |
APYX | Apyx Medical | $52.35M | $12.15M |
CVRX | CVRx | $39.30M | $11.81M |
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
TLIS | Talis Biomedical | $412.00K | - |
OFIX | Orthofix Medical | $100.00K | $198.62M |
RXST Revenue FAQ
What is RxSight’s yearly revenue?
RxSight's yearly revenue for 2023 was $89.08M, representing an increase of 81.77% compared to 2022. The company's yearly revenue for 2022 was $49M, representing an increase of 116.90% compared to 2021. RXST's yearly revenue for 2021 was $22.59M, representing an increase of 53.92% compared to 2020.
What is RxSight’s quarterly revenue?
RxSight's quarterly revenue for Q2 2024 was $45.52M, a 54.26% increase from the previous quarter (Q1 2024), and a 118.76% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $29.51M, a 3.26% increase from the previous quarter (Q4 2023), and a 68.75% increase year-over-year (Q1 2023). RXST's quarterly revenue for Q4 2023 was $28.58M, a -6.81% decrease from the previous quarter (Q3 2023), and a 77.65% increase year-over-year (Q4 2022).
What is RxSight’s revenue growth rate?
RxSight's revenue growth rate for the last 3 years (2021-2023) was 294.27%, and for the last 5 years (2019-2023) was 3874.88%.
What are RxSight’s revenue streams?
RxSight's revenue streams in c 21 are Service Warranty Service Contracts And Accessories, L A L, and L D D. Service Warranty Service Contracts And Accessories generated $656K in revenue, accounting 2.90% of the company's total revenue L A L generated $8.16M in revenue, accounting 36.13% of the company's total revenue L D D generated $13.77M in revenue, accounting 60.97% of the company's total revenue
What is RxSight’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of RxSight was L D D. This segment made a revenue of $13.77M, representing 60.97% of the company's total revenue.